Momenta Pharmaceuticals, Inc. (MNTA) financial statements (2021 and earlier)

Company profile

Business Address 301 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:545449380353350192246
Cash and cash equivalents3832487415161 30
Short-term investments139174269202289130216
Other undisclosed cash, cash equivalents, and short-term investments232737  61 
Restricted cash and investments  2    
Receivables811157019713
Other undisclosed current assets(14)(19)(30)5567
Total current assets:539441367428375205266
Noncurrent Assets
Property, plant and equipment11213021222525
Long-term investments and receivables232737    
Long-term investments232737    
Intangible assets, net (including goodwill)2345456
Intangible assets, net (excluding goodwill)2345456
Restricted cash and investments2382122212121
Other noncurrent assets41112000
Total noncurrent assets:79909350465151
TOTAL ASSETS:618532459478421256317
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities73233230292524
Accounts payable149114476
Accrued liabilities59142127241011
Employee-related liabilities     77
Deferred revenue1
Restructuring reserve03    
Deferred revenue and credits371054
Contract with customer, liability4
Other liabilities281600010
Other undisclosed current liabilities45933 (7)(7)
Total current liabilities:106524471392422
Noncurrent Liabilities
Liabilities, other than long-term debt58194135122625
Deferred revenue and credits3131122624
Deferred revenue1
Contract with customer, liability2
Other liabilities5717104011
Total noncurrent liabilities:58194135122625
Total liabilities:1647185106515047
Stockholders' equity
Stockholders' equity attributable to parent454461374372370206270
Common stock0000000
Treasury stock, value(3)(3)(3)(3)(2)  
Additional paid in capital1,4911,208940848824575540
Accumulated other comprehensive income (loss)0(0)(0)00(0)0
Accumulated deficit(1,034)(744)(562)(473)(452)(369)(270)
Total stockholders' equity:454461374372370206270
TOTAL LIABILITIES AND EQUITY:618532459478421256317

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net139110905235
Gross profit:2476139110905235
Operating expenses(322)(257)(231)(184)(174)(152)(145)
Operating loss:(298)(181)(93)(75)(84)(99)(110)
Nonoperating income85454111
Investment income, nonoperating9642111
Other nonoperating income (expense)1(1)051000
Interest and debt expense(2)      
Net loss attributable to parent:(292)(176)(88)(21)(83)(99)(108)
Other undisclosed net income available to common stockholders, basic2      
Net loss available to common stockholders, diluted:(290)(176)(88)(21)(83)(99)(108)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(292)(176)(88)(21)(83)(99)(108)
Comprehensive loss:(292)(176)(88)(21)(83)(99)(108)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent20(0)00(0)(0)
Comprehensive loss, net of tax, attributable to parent:(290)(176)(88)(21)(83)(99)(108)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: